Genomics

Turning precision medicine into a reality

Explore how Philips is using technology to revolutionize cancer care

Turning precision medicine into a reality

Explore how Philips is using technology to revolutionize cancer care

Cancer affects us all. Millions of people around the world are living with the disease and every year, millions more are newly diagnosed.
 

According to the National Cancer Institute, patients today usually receive the same treatment as others who have same type and stage of cancer despite growing evidence that they may respond differently.
 

Philips approach to precision medicine is to arm care teams with expert clinical guidance and a holistic view of the patient’s genotypic and phenotypic information in order to make decisions efficiently, collaboratively and accurately.
 

Recognizing the growing need for technological advancement in comprehensive oncology care (from early detection to diagnosis to treatment to survivorship), Philips vision to become an innovation leader in precision medicine with personalized patient/clinician-centered solutions that connect areas such as pathology, genomics, molecular/multi-disciplinary tumor boards, therapy decision making, molecular phenotyping, and more.

End-to-end Oncology Care

ispm

IntelliSpace Precision Medicine

Our IntelliSpace Precision Medicine(ISPM) platform is made up of three core components: a virtual tumor board, oncology pathways, and genomics. These are informatics solutions that aim to help clinicians in their own way in regards to cancer care. With our virtual tumor board we are able to integrate scan summaries, lab results, and more into one screen so tumor board meetings can be more efficient and more collaborative. Our oncology pathways solution is in joint partnership with Dana-Farber Cancer Center to address the difficulties in therapy selection. With our technology oncologists are now able to map a patient’s unique characteristics to a therapy that is best suited for them and provides evidence on why that therapy is best. Our genomics solution combines individual institution genomic knowledgebases and general industry knowledgebases, to help molecular pathologists interpret genomic data and to provide clinicians with ways to better treat their patients.
oncosignal infographic

OncoSignal

Philips MPDx is active in the development and commercialization of molecular diagnostic tests that measure the activity of signal transduction pathways in cancer cells. OncoSignal tests can be used by pathologists and oncologists to select the appropriate  treatment for their patients, and by clinical research organizations (CROs) and pharma companies to investigate the efficacy of new targeted anti-cancer drugs during (pre)clinical research.

Key opportunities to show value

clinicians checking reports and talking
The key to Philips take on precision medicine is our integration capabilities. We are able to take information from previous silo-ed departments like pathology and include them in our workflows for more collaborative therapy treatment decisions.

Explore more topics

Feel protected with Philips
Our IntelliSpace Precision Medicine platform is a SAAS and hosted on our Philips Healthsuite cloud. Learn more about how we put your security at the forefront.
Integrate patient information into your virtual tumor board
Make your tumor board meetings more effective by integrating all your patient’s data onto a single screen. With IntelliSpace Precision Medicine Oncology, you can view your patient’s scan summaries, lab results, treatment timeline, and more – all on one screen.

Building partnerships.
Breaking barriers.

We work in partnership with health systems to help drive innovation, support their financial and operational goals, and enable their transformation in a value-driven era. The result can be both operational excellence and more connected, predictive and personalized care delivery.
See how we can support you across your enterprise.

Clinical Trial Matching

Customer challenges

  • Low clinical trial participation given limited access at local hospitals.
  • Matching patients to clinical trials is time-consuming (often requiring multiple databases) and complex (e.g. given inclusion and exclusion criteria)
  • Lack of structured reporting of patient clinical statistics relevant for clinical trial enrollment (e.g. mutations)
representative talking to clinicians

Philips solution

Our clinical trial curation system relies on advanced informatics technology to help you curate in-house and works with MD Anderson and clinicaltrials.gov for automated clinical trial matching.
representative talking to clinicians

Philips solution

Clinical trial curation system relying on advanced informatics technologies to help you curate your in-house and clinicaltrials.gov for automated clinical trial matching for genomics.

News

  • Philips IntelliSpace Precision Medicine Oncology Pathways powered by Dana-Farber is now live

    Philips IntelliSpace Precision Medicine Oncology Pathways powered by Dana-Farber is now live

    Learn more
  • Miami Cancer Institute adopts Philips IntelliSpace Precision Medicine Genomics

    Miami Cancer Institute adopts Philips IntelliSpace Precision Medicine Genomics

    Learn more

Blog

Genomic findings are most useful when presented within the clinical context of a patient – the relevant personal attributes and medical history, along with radiology images and pathology findings.

Awards

UX Design Awards

IntelliSpace Precision Medicine Genomics converts massive data sets involved in genomic analysis into clinically actionable information – providing a holistic and lucid workflow for oncologists, pathologists and counselors throughout cancer care.

Frost & Sullivan - 2018 Global Oncology Informatics Customer Value Leadership Award

Frost & Sullivan celebrated innovative companies at its Excellence in Best Practices Awards Gala on Wednesday night at the Hyatt Regency in La Jolla, CA.
*

Contact information

* This field is mandatory
*
*
*
*
*
*
*
*
*
By specifying your reason for contact we will be able to provide you with a better service.
We work with partners and distributors who may contact you about this Philips product on our behalf.
*
*

Final CEE consent

1. Xplore is not intended for diagnostic, monitoring or therapeutic purposes or in any other manner for regular medical practice.

2. Philips Electronics Nederland B.V. is the legal manufacturer of Xplore.